All Stories

  1. Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes
  2. Novel psychoactive substance use in the European Union
  3. Editorial
  4. Guanfacine XR for ADHD
  5. Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder
  6. Attention-deficit hyperactivity disorder (ADHD), substance use disorders, and criminality: a difficult problem with complex solutions
  7. Dual Diagnosis Resource Needs in Spain: A National Survey of Professionals
  8. Professionals’ perceptions about healthcare resources for co-occuring disorders in Spain
  9. Addressing Dual Diagnosis Patients Suffering from Attention-Deficit Hyperactivity Disorders and Comorbid Substance Use Disorders
  10. Rethinking Dual Disorders/Pathology
  11. Nutritional Education of Secondary Education Students and Diet Quality
  12. Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition
  13. Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder
  14. Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
  15. Indicadores de calidad asistencial de GESIDA para la atención de personas infectadas por el virus de la inmunodeficiencia adquirida/sida y metadona
  16. A Review of “Encounter Groups for Addictions: The Therapeutic Community Training Series”
  17. Consumo adictivo de sustancias psicoactivas
  18. Suboxone® (Buprenorphine/Naloxone) as an Agonist Opioid Treatment in Spain: A Budgetary Impact Analysis
  19. Gluten as a precipitating factor of autoimmune diseases other than celiac disease
  20. Modafinil: A Useful Medication for Cocaine Addiction? Review of the Evidence from Neuropharmacological, Experimental and Clinical Studies
  21. Influence of fruit intake and antioxidants on the prevention of opacities of the lens
  22. Alcohol consumption in secondary-school students: effects on plasma total antioxidant capacity
  23. Dr. Francisco José Martínez Tello
  24. Antipsychotic Drug Treatment of Schizophrenic Patients with Substance Abuse Disorders
  25. One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving
  26. Does Anyone Care about Names? How Attendees at Substance Misuse Services Like to Be Addressed by Health Professionals
  27. Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile
  28. Drug counseling for cocaine addiction: The Collaborative Cocaine Treatment Study Model
  29. Homosexual Delusional Jealousy in Two Heterosexual Women
  30. The role of the psychiatrist in the treatment of alcoholic liver disease
  32. Positive or negative history of childhood sexual abuse among problem drinkers: relationship to substance use disorders and psychiatric co-morbidity
  33. Hepatitis B and C in alcohol-dependent patients admitted to a UK alcohol inpatient treatment unit
  34. Impact of family history of alcoholism on cocaine-induced subjective effects and pharmacokinetic profile
  35. What Makes Alcohol-Dependent Individuals Early in Abstinence Crave for Alcohol
  36. What Makes Alcohol-Dependent Individuals Early in Abstinence Crave for Alcohol: Exposure to the Drink, Images of Drinking, or Remembrance of Drinks Past?
  37. The Significance of a Coexisting Opioid Use Disorder in Cocaine Dependence: An Empirical Study
  38. Personality disorders in a sample of Spanish drug dependent patients admitted for inpatient detoxification
  39. 13. Attention-deficit hyperactivity disorder and dual disorders: educational needs for an underdiagnosed condition